0001567619-20-001131.txt : 20200116 0001567619-20-001131.hdr.sgml : 20200116 20200116121309 ACCESSION NUMBER: 0001567619-20-001131 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200116 DATE AS OF CHANGE: 20200116 EFFECTIVENESS DATE: 20200116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aligos Therapeutics, Inc. CENTRAL INDEX KEY: 0001799448 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358226 FILM NUMBER: 20530066 BUSINESS ADDRESS: STREET 1: ONE CORPORATE DR., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (800) 466-6059 MAIL ADDRESS: STREET 1: ONE CORPORATE DR., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001799448 Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 (800) 466-6059 DELAWARE Aligos, Inc. None Corporation true 2018 Lawrence Blatt c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director Chief Executive Officer Leonid Beigelman c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Director President Lucinda Quan c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Executive Vice President - General Counsel Brian Dowd c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Executive Vice President - Controller John Fry c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Executive Vice President - Clinical Development Julian Symons c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Executive Vice President - Chief Scientific Officer Sushmita Chanda c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Executive Officer Executive Vice President - Preclinical Development Peter Moldt c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Jack Nielsen c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Carole Neuchterlein c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Peter Hirth c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Tom Woiwode c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Kathleen Glaub c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Michael Yi c/o Aligos Therapeutics, Inc. One Corporate Dr., 2nd Floor South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2019-12-23 false true false 0 125000167 85000001 40000166 false 38 0 0 0 false Aligos Therapeutics, Inc. /s/ Lawrence Blatt Lawrence Blatt Chief Executive Officer 2020-01-09